Research location
Taranto
Italy
Advertisement
Research activity in Taranto
ItalyCureCurrent currently publishes aggregate city-level research activity for this location: 15 trials and 15 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Taranto
15 linked trials · page 1 of 1BIO|STREAM.CSP StudyNCT07393009 · 2026-05-25 · 1 site observation
RECRUITING
Effects of Oxygen Supplementation During the 6-Minute Walk Test in Chronic Respiratory Failure or Exertional HypoxemiaNCT07451977 · 2026-04-02 · 1 site observation
RECRUITING
An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in EuropeNCT05363319 · 2022-10-26 · 1 site observation
RECRUITING
Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)NCT04996017 · 2021-12-14 · 1 site observation
RECRUITING
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsNCT00271180 · 1983-01-01 · 1 site observation
RECRUITING
Standardized Italian netwoRk Enrolling iNdividuals With Islet-AutoantibodiesNCT07503366 · 2026-05-01 · 1 site observation
NOT_YET_RECRUITING
Safety and Performance of INVICTA Ventricular DF4 LEADS With Active Fixation-(APOLLO)NCT04590144 · 2021-06-04 · 1 site observation
COMPLETED
Personalized Therapy Study - HFRS (TriageHF) Post Approval StudyNCT04489225 · 2020-08-01 · 1 site observation
ACTIVE_NOT_RECRUITING
COVID19-hematological Malignancies: the Italian Hematology AllianceNCT04352556 · 2020-04-07 · 1 site observation
UNKNOWN
Pembrolizumab (MK-3475) as Maintainance in Treated Patients With Unresectable Stage III NSCLCNCT03379441 · 2018-01-01 · 1 site observation
UNKNOWN
Personalized Therapy Study - Attain Stability Quad Post-Approval StudyNCT04024943 · 2017-08-21 · 1 site observation
ACTIVE_NOT_RECRUITING
Dexamethasone-sparing Approach Including NEPA Against Emesis Caused by CisplatinNCT04201769 · 2016-11-25 · 1 site observation
UNKNOWN
Selection of Potential Predictors of Worsening Heart FailureNCT01836510 · 2012-05-01 · 1 site observation
COMPLETED
More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions to CRT ChallengesNCT01510652 · 2011-11-01 · 1 site observation
COMPLETED
Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With SchizophreniaNCT00139737 · 2002-03-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.